688278 特寶生物
按盤價 
63.250 +2.750 (+4.545%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 15.646 | 33.828 | 22.346 | 16.765 | 14.907 |
| 總資產報酬率 ROA (%) | 12.785 | 26.925 | 17.972 | 13.848 | 11.760 |
| 投入資產回報率 ROIC (%) | 14.841 | 32.277 | 21.400 | 16.036 | 13.860 | 邊際利潤分析 |
| 銷售毛利率 (%) | 93.363 | 93.332 | 88.916 | 88.948 | 89.464 |
| 營業利潤率 (%) | 32.379 | 32.410 | 26.650 | 21.950 | 19.919 |
| 息稅前利潤/營業總收入 (%) | 30.608 | 30.274 | 23.037 | 18.918 | 17.624 |
| 淨利潤/營業總收入 (%) | 25.579 | 26.446 | 18.797 | 16.004 | 14.683 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.040 | 103.762 | 101.885 | 102.294 | 90.375 |
| 價值變動淨收益/利潤總額(%) | 0.694 | 0.967 | 1.101 | 3.151 | 3.483 |
| 營業外收支淨額/利潤總額(%) | -5.373 | -6.254 | -14.328 | -15.441 | -13.715 | 償債能力分析 |
| 流動比率 (X) | 4.075 | 3.320 | 3.567 | 4.708 | 6.724 |
| 速動比率 (X) | 3.344 | 2.857 | 3.083 | 4.051 | 5.857 |
| 資產負債率 (%) | 16.251 | 20.359 | 20.469 | 18.461 | 16.126 |
| 帶息債務/全部投入資本 (%) | 1.670 | 1.194 | -2.475 | -2.488 | -3.315 |
| 股東權益/帶息債務 (%) | 5,673.123 | 7,950.842 | -3,880.651 | -3,836.142 | -2,892.803 |
| 股東權益/負債合計 (%) | 515.351 | 391.173 | 388.546 | 441.687 | 520.135 |
| 利息保障倍數 (X) | -255.666 | -132.170 | -84.160 | -196.146 | 164.167 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.986 | 56.125 | 47.562 | 55.529 | 65.105 |
| 存貨周轉天數 (天) | 475.396 | 407.086 | 261.874 | 310.866 | 366.276 |
| 備註： | 即時報價更新時間為 27/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
